Pacira Pharmaceuticals (PCRX) Announces Quarterly Results
Pacira Pharmaceuticals (NASDAQ:PCRX) issued its quarterly earnings data on Tuesday. The company reported ($0.33) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.31) by $0.02, AmericanBankingNews.com reports.
Shares of Pacira Pharmaceuticals (NASDAQ:PCRX) opened at 73.33 on Tuesday. Pacira Pharmaceuticals has a 1-year low of $20.52 and a 1-year high of $74.60. The stock’s 50-day moving average is $65.16 and its 200-day moving average is $52.16. The company’s market cap is $2.459 billion.
Pacira Pharmaceuticals, Inc is a United States-based pharmaceutical company. The Company develops non-opioid products for postsurgical pain control.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.